Gene-gene and gene-environment interaction on the risk of parkinson’s disease

Current Aging Science

Volumn 7, Issue 2, 2014, Pages 101-109

  Singh, Neeraj Kumar ^a   Banerjee, Basu Dev ^b   Bala, Kiran ^a   Chhillar, Mitrabasu ^c   Chhillar, Neelam ^a  

^a INSTITUTE OF HUMAN BEHAVIOUR AND ALLIED SCIENCES   (India)

^b UNIVERSITY COLLEGE OF MEDICAL SCIENCES   (India)

^c INSTITUTE OF NUCLEAR MEDICINE AND ALLIED SCIENCES   (India)

Author keywords

CYP2D6 gene; Dieldrin; GSTP1 gene; GxE; Neurodegenerative disease; Serum copper; HCH

Indexed keywords

1,1 DICHLORO 2,2 BIS(4 CHLOROPHENYL)ETHYLENE; BETA HEXACHLOROCYCLOHEXANE; COPPER; CYTOCHROME P450 2D6; DIELDRIN; GENOMIC DNA; GLUTATHIONE TRANSFERASE; ORGANOCHLORINE PESTICIDE; CHLORINATED HYDROCARBON; GLUTATHIONE TRANSFERASE P1; GSTP1 PROTEIN, HUMAN; METAL; PESTICIDE;

ADULT; ALCOHOL CONSUMPTION; ALLELE; ARTICLE; CONTROLLED STUDY; COPPER BLOOD LEVEL; DNA POLYMORPHISM; ENVIRONMENTAL FACTOR; FEMALE; GENE AMPLIFICATION; GENE FREQUENCY; GENE INTERACTION; GENETIC RISK; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MOLECULAR WEIGHT; PARKINSON DISEASE; PRIORITY JOURNAL; QUALITY CONTROL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; XENOBIOTIC METABOLISM; AGED; BLOOD; CASE CONTROL STUDY; CHEMICALLY INDUCED; ENZYMOLOGY; EPISTASIS; GENETIC PREDISPOSITION; GENETICS; METABOLISM; PARKINSON DISEASE, SECONDARY; PHENOTYPE; RISK FACTOR; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CYTOCHROME P-450 CYP2D6; EPISTASIS, GENETIC; FEMALE; GENE FREQUENCY; GENE-ENVIRONMENT INTERACTION; GENETIC PREDISPOSITION TO DISEASE; GLUTATHIONE S-TRANSFERASE PI; HUMANS; HYDROCARBONS, CHLORINATED; MALE; METALS; MIDDLE AGED; PARKINSON DISEASE; PARKINSON DISEASE, SECONDARY; PESTICIDES; PHENOTYPE; RISK FACTORS;

EID: 84921383480     PISSN: 18746098     EISSN: 18746128     Source Type: Journal    
DOI: 10.2174/1874609807666140805123621     Document Type: Article

References (43)

1. [1] Nussbaum RL, Ellis CE. Alzheimer's disease and Parkinson's dis-ease. N Engl J Med 2003; 348(14): 1356-64.
2. [2] Do CB, Tung JY, Dorfman E, Kiefer AK, Drabant EM, Francke U, et al. Web-based genome-wide association study identifies two novel loci and a substantial genetic component for Parkinson's disease. PLoS Genet 2011; 7(6): e1002141.
3. [3] International Parkinson Disease Genomics Consortium, Nalls MA, Plagnol V, Hernandez DG, et al. Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies. Lancet 2011; 377(9766): 641-9.
4. [4] International Parkinson's Disease Genomics Consortium (IPDGC); Wellcome Trust Case Control Consortium 2 (WTCCC2). A two-stage meta-analysis identifies several new loci for Parkinson's disease. PLoS Genet 2011; 7(6): e1002142.
5. [5] Kwok JB. Role of epigenetics in Alzheimer's and Parkinson's dis-ease. Epigenomics 2010; 2(5): 671-82.
6. [6] Abhilash PC, Singh N. Pesticide use and application: an Indian scenario. J Hazard Mater 2009; 165(1-3): 1-12.
7. [7] Weisskopf MG, Knekt P, O'Reilly EJ, et al. Persistent organochlo-rine pesticides in serum and risk of Parkinson disease. Neurology 2010; 74(13): 1055-61.
8. [8] Richardson JR, Roy A, Shalat SL, et al. β-Hexachlorocyclohexane levels in serum and risk of Parkinson's disease. Neurotoxicology 2011; 32(5): 640-5.
9. [9] Chhillar N, Singh NK, Banerjee BD, et al. Organochlorine pesti-cide levels and risk of Parkinson's disease in north Indian population. ISRN Neurol 2013; 2013: 371034.
10. [10] Jardine C, Hrudey S, Shortreed J, et al. Risk management frameworks for human health and environmental risks. J Toxicol Environ Health B Crit Rev 2003; 6(6): 569-720.
11. [11] Bon MA, Jansen Steur EN, de Vos RA, Vermes I. Neurogenetic correlates of Parkinson's disease: apolipoprotein-E and cytochrome P450 2D6 genetic polymorphism. Neurosci Lett 1999; 266(2): 149-51.
12. [12] Woo SI, Kim JW, Seo HG, et al. CYP2D6*4 polymorphism is not associated with Parkinson's disease and has no protective role against Alzheimer's disease in the Korean population. Psychiatry Clin Neurosci 2001; 55(4): 373-7.
13. [13] Elbaz A, Levecque C, Clavel J, et al. CYP2D6 polymorphism, pesticide exposure, and Parkinson's disease. Ann Neurol 2004; 55(3): 430-4.
14. [14] Singh M, Khan AJ, Shah PP, Shukla R, Khanna VK, Parmar D. Polymorphism in environment responsive genes and association with Parkinson disease. Mol Cell Biochem 2008; 312(1-2): 131-8.
15. [15] Singh M, Khanna VK, Shukla R, Parmar D. Association of polymorphism in cytochrome P450 2D6 and N-acetyltransferase-2 with Parkinson's disease. Dis Markers 2010; 28(2): 87-93.
16. [16] Sharma H, Zhang P, Barber DS, Liu B. Organochlorine pesticides dieldrin and lindane induce cooperative toxicity in dopaminergic neurons: role of oxidative stress. Neurotoxicology 2010; 31(2): 215-22.
17. [17] Pathak R, Mustafa MD, Ahmed T, et al. Intra uterine growth retardation: association with organochlorine pesticide residue levels and oxidative stress markers. Reprod Toxicol 2011; 31(4): 534-9.
18. [18] Hwang O. Role of oxidative stress in Parkinson's disease. Exp Neurobiol 2013; 22(1): 11-7.
19. [19] Subramaniam SR, Chesselet MF. Mitochondrial dysfunction and oxidative stress in Parkinson's disease. Prog Neurobiol 2013; 106-107: 17-32.
20. [20] Vilar R, Coelho H, Rodrigues E, et al. Association of A313 G polymorphism (GSTP1*B) in the glutathione-S-transferase P1 gene with sporadic Parkinson's disease. Eur J Neurol 2007; 14(2): 156-61.
21. [21] Cornetta T, Patrono C, Terrenato I, et al. Epidemiological, clinical, and molecular study of a cohort of Italian Parkinson disease patients: association with glutathione-S-transferase and DNA repair gene polymorphisms. Cell Mol Neurobiol 2013; 33(5): 673-80.
22. [22] Desai V, Kaler SG. Role of copper in human neurological disorders. Am J Clin Nutr 2008; 88(3): 855S-8S.
23. [23] Squitti R. Copper dysfunction in Alzheimer's disease: from meta-analysis of biochemical studies to new insight into genetics. J Trace Elem Med Biol 2012; 26(2-3): 93-6.
24. [24] Martyn CN, Coggon DN, Inskip H, Lacey RF, Young WF. Aluminum concentrations in drinking water and risk of Alzheimer's disease. Epidemiology 1997; 8(3): 281-6.
25. [25] Gauthier E, Fortier I, Courchesne F, Pepin P, Mortimer J, Gauvreau D. Aluminum forms in drinking water and risk of Alzheimer's disease. Environ Res 2000; 84(3): 234-46.
26. [26] Forte G, Alimonti A, Pino A, et al. Metals and oxidative stress in patients with Parkinson's disease. Ann Ist Super Sanita 2005; 41(2): 189-95.
27. [27] Mustafa M, Pathak R, Tripathi AK, Ahmed RS, Guleria K, Baner-jee BD. Maternal and cord blood levels of aldrin and dieldrin in Delhi population. Environ Monit Assess 2010; 171(1-4): 633-8.
28. [28] Singh N, Chhillar N, Banerjee B, Bala K, Basu M, Mustafa M. Organochlorine pesticide levels and risk of Alzheimer's disease in north Indian population. Hum Exp Toxicol 2013; 32(1): 24-30.
29. [29] Naveen AT, Adithan C, Soya SS, Gerard N, Krishnamoorthy R. CYP2D6 genetic polymorphism in South Indian populations. Biol Pharm Bull 2006; 29(8): 1655-8.
30. [30] Hemmingsen A, Fryer AA, Hepple M, Strange RC, Spiteri MA. Simultaneous identification of GSTP1 Ile105-->Val105 and Ala114-->Val114 substitutions using an amplification refractory mutation system polymerase chain reaction assay: studies in patients with asthma. Respir Res 2001; 2(4): 255-60.
31. [31] Quik M, Perez XA, Bordia T. Nicotine as a potential neuroprotec-tive agent for Parkinson's disease. Mov Disord 2012; 27(8): 947-57.
32. [32] Liu R, Guo X, Park Y, et al. Caffeine intake, smoking, and risk of Parkinson disease in men and women. Am J Epidemiol 2012; 175(11): 1200-7.
33. [33] Greenbaum L, Rigbi A, Lipshtat N, et al. Association of nicotine dependence susceptibility gene, CHRNA5, with Parkinson's disease age at onset: gene and smoking status interaction. Parkinsonism Relat Disord 2013; 19(1): 72-6.
34. [34] Henley BM, Williams BA, Srinivasan R, et al. Transcriptional regulation by nicotine in dopaminergic neurons. Biochem Pharmacol 2013; 86(8): 1074-83.
35. [35] Santt O, Baranova H, Albuisson E, Bignon YJ, Lucotte G. Interaction between GSTM1-null and CYP2D6-deficient alleles in the pathogenesis of Parkinson's disease. Eur J Neurol 2004; 11(4): 247-51.
36. [36] Baez S, Segura-Aguilar J, Widersten M, Johansson AS, Mannervik B. Glutathione transferases catalyse the detoxication of oxidized metabolites (o-quinones) of catecholamines and may serve as an antioxidant system preventing degenerative cellular processes. Bio-chem J 1997; 324 (Pt 1): 25-8.
37. [37] Wang C, Liu L, Zhang L, Peng Y, Zhou F. Redox reactions of the α-synuclein-Cu(2+) complex and their effects on neuronal cell viability. Biochemistry 2010; 49(37): 8134-42.
38. [38] Uversky VN, Li J, Fink AL. Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure. J Biol Chem 2001; 276(47): 44284-96.
39. [39] Drechsel DA, Patel M. Role of reactive oxygen species in the neu-rotoxicity of environmental agents implicated in Parkinson's disease. Free Radic Biol Med 2000; 44(11): 1873-86.
40. [40] Mazzio E, Soliman KF. Whole genome expression profile in neu-roblastoma cells exposed to 1-methyl-4-phenylpyridine. Neurotoxi-cology 2012; 33(5): 1156-69.
41. [41] Lahiri DK, Maloney B, Zawia NH. The LEARn model: an epige-netic explanation for idiopathic neurobiological diseases. Mol Psychiatry 2009; 14(11): 992-1003.
42. [42] Lahiri DK, Maloney B, Basha MR, Ge YW, Zawia NH. How and when environmental agents and dietary factors affect the course of Alzheimer's disease: the "LEARn" model (latent early-life associated regulation) may explain the triggering of AD. Curr Alzheimer Res 2007; 4(2): 219-28.
43. [43] Lahiri DK, Maloney B. The "LEARn" (Latent Early-life Associated Regulation) model integrates environmental risk factors and the developmental basis of Alzheimer's disease, and proposes remedial steps. Exp Gerontol 2010; 45(4): 291-6.